Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Value of Good Boiler Blowdown Control

A Critical Component of the Boiler Water Treatment Program In a steam boiler system, blowdown involves removing a portion of the concentrated boiler water and replacing it with feedwater, which is a mixture of condensate and makeup water. Good blowdown control is a critical component of the boiler water treatment program.  Boiler blowdown is heated,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

A Critical Component of the Boiler Water Treatment Program

In a steam boiler system, blowdown involves removing a portion of the concentrated boiler water and replacing it with feedwater, which is a mixture of condensate and makeup water.

Good blowdown control is a critical component of the boiler water treatment program. Boiler blowdown is heated, treated feedwater that is sent to the drain instead of converted into steam. Blowdown is used to control the dissolved and suspended solids level in a boiler within the range necessary to minimize scale deposits and carryover. Too much blowdown increases fuel, water, and treatment requirements. Too little blowdown can cause scale deposits and wet steam (carryover).

There are two types of boiler blowdown.

  • Surface Blowdown: A continuous or intermittent process designed to remove the dissolved solids that concentrate near the liquid’s surface using a graduated needle valve or motorized valve actuated by a boiler blowdown controller.
  • Bottom Blowdown: A manual procedure to remove accumulated sediment and sludge from the bottom of the boiler (e.g., mud drum). This procedure is typically performed for a few seconds once every shift or, in smaller boilers, once a day.

The blowdown rate is expressed as a percentage of feedwater flow rate, and determined by the feedwater “cycles of concentration” that are maintained in the boiler. The feedwater cycles reflect the extent impurities in the feedwater concentrate in the boiler water.

The higher the feedwater cycles, the more the feedwater impurities have been concentrated in the boiler water and the lower the blowdown rate. As in cooling tower systems, the cycles of concentration is usually estimated by measuring the relative levels of a soluble impurity in the boiler water and feedwater.

Blowdown is Necessary to Keep Boilers Running Efficiently

Boiler blowdown rates typically range from 2% to 10% of the feedwater flow rate, but can be much higher if the condensate return is low or the makeup water quality is poor. The optimum blowdown rate for a particular boiler system is determined by various factors including:

  • Boiler design
  • Makeup water quality
  • Operating conditions
  • Feed/control equipment
  • Treatment product selection
  • Degree of onsite monitoring

Chem-Aqua Can Help You Determine Your Optimal Boiler Blowdown Rate

Blowdown is necessary to remove impurities in your boiler water system and keep it running efficiently. In order to ensure safe, reliable, and cost-effective steam production, it is essential to optimize your boiler’s blowdown rate. Chem-Aqua is a resourcefully green leader in boiler water treatment solutions.

A customized water treatment program from Chem-Aqua can help you determine the optimal blowdown rate to maximize energy efficiency and to protect your boiler system from the harmful effects of corrosion, scale, and carryover.

Read more at chemaqua.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512